Morphologic and Immunophenotypic Diversity in Ewing Family Tumors
CD99
CD117
Primitive neuroectodermal tumor
Immunophenotyping
Ewing's sarcoma
Adamantinoma
DOI:
10.1097/01.pas.0000167056.13614.62
Publication Date:
2021-05-10T09:26:38Z
AUTHORS (7)
ABSTRACT
More than 85% of Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET), or "Ewing family tumors" (EFTs), have the translocation, t (11;22) (q24;q12), with others having variant translocations. Identification these by cytogenetic and/or molecular genetic techniques is specific for EFT and increasingly recognized as "gold standard" diagnosis. However, are not universally available. We therefore studied a large group genetically confirmed EFTs to more completely understand morphologic immunophenotypic spectrum this rare sarcoma. Sixty-six cytogenetically, FISH RT-PCR proven-EFTs were retrieved. In 56 cases, immunohistochemistry (IHC) was performed pan-cytokeratins (PanCK), high weight cytokeratins (HMWCK), desmin (DES), CD99, CD117, FLI1 protein using heat-induced epitope retrieval Dako Envision system. The cases arose chiefly in children young adults (median 18 years; range, 3-65 years) both sexes (male, 32; female, 31; unknown, 3) variety bone (N = 39) soft tissue 27) sites. Histologically, 46 (73%) showed only typical features ES, 9 (16%) PNET, 3 (5%) "adamantinoma-like" features, corresponded "atypical sarcoma," principally intersecting fascicles spindled cells, 2 had abundant hyalinized matrix. IHC results follows: PanCK (18 56, 32%), HMWCK (3 55, 5%), DES (1 2%), CD99 (52 52, 100%), CD117 (13 54, 24%), (44 47, 94%). expressed EFTs, none which DES. conclusion, most, but all, can be accurately diagnosed time-honored criteria ancillary immunohistochemistry. confirmation remains essential diagnosis unusual variants EFT, including "adamantinoma-like," spindled, sclerosing, clear cell/anaplastic variants. Therefore, exclude confirm Ewing's sarcoma round cell sarcomas patterns specifically conforming known lineage (eg, rhabdomyosarcoma), cytogenetics, analysis required.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (54)
CITATIONS (352)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....